We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn how hysteroscopy, a procedure using a camera-guided instrument, helps doctors diagnose and sometimes treat uterine cancer by visualizing and sampling the uterine lining. Understand its role alongside other diagnostic methods and what to expect.

Uterine cancer, particularly endometrial cancer, which originates in the inner lining of the uterus, affects many women. Fortunately, medical advancements have provided effective diagnostic and treatment tools. Among these, hysteroscopy stands out as a minimally invasive procedure that offers a direct view of the uterine cavity, aiding significantly in the detection and management of uterine cancer. This blog post delves into what hysteroscopy is, how it's used in diagnosing uterine cancer, its potential role in treatment, and other diagnostic methods.
Hysteroscopy is a medical procedure that allows doctors to examine the inside of the uterus. It involves using a hysteroscope, a slender, flexible instrument equipped with a light and a camera. This device is gently inserted through the vagina, then through the cervix, and into the uterus. To improve visibility, a saline solution or gas is often introduced through the hysteroscope to expand the uterine cavity. The camera transmits real-time images to a monitor, enabling the doctor to meticulously inspect the uterine lining.
Uterine cancer, with endometrial cancer accounting for about 80% of cases, often presents with symptoms like abnormal uterine bleeding. This bleeding can manifest as periods that are heavier, longer, or more irregular than usual, or bleeding that occurs after menopause. While these symptoms can be caused by benign conditions like fibroids or polyps, they can also be indicative of uterine cancer. Hysteroscopy plays a crucial role in differentiating these conditions.
The primary advantage of hysteroscopy in cancer diagnosis is its ability to provide direct visualization of the uterine lining. Unlike older methods like dilation and curettage (D&C), which involve taking random tissue samples, hysteroscopy allows for a directed biopsy. If the doctor identifies any suspicious areas or lesions during the visual examination, they can use specialized instruments passed through the hysteroscope to collect a tissue sample directly from that specific area. This targeted approach significantly increases the accuracy of diagnosis compared to blind sampling.
Dilation and curettage (D&C) is another procedure used to diagnose uterine conditions. It involves dilating the cervix and using a curette to scrape tissue from the uterine lining. While D&C can obtain tissue samples, it is often considered a 'blind' procedure because the sample is not directly visualized. Hysteroscopy, by allowing direct visualization and targeted biopsy, is generally considered more accurate for diagnosing uterine cancer, as it ensures that any abnormal areas are specifically examined.
In certain specific situations, hysteroscopy can also play a role in the treatment of uterine cancer. For individuals diagnosed with early-stage (Stage 1) and low-grade uterine cancer that is confined to the uterus, hysteroscopy may be used to remove the cancerous tissue. This is particularly relevant for women who wish to preserve their fertility or for those who are not candidates for more extensive surgery. However, it's important to note that the standard treatment for uterine cancer typically involves surgery, such as a hysterectomy (removal of the uterus), often along with the removal of fallopian tubes and ovaries (bilateral salpingo-oophorectomy).
For women with early-stage uterine cancer who desire to maintain their fertility, hysteroscopic procedures combined with hormonal therapy can be an option. This approach aims to treat the cancer while preserving the uterus, allowing for future pregnancy. However, this is a specialized treatment that requires careful consideration and close monitoring by a medical team.
While hysteroscopy is a powerful diagnostic tool, it is usually part of a broader diagnostic workup for uterine cancer. Doctors employ a combination of methods to ensure an accurate diagnosis:
Hysteroscopy is generally performed as an outpatient procedure, meaning you can usually go home the same day. Many women undergo the procedure while awake, with a local anesthetic to numb the cervix and uterus. You might feel some pressure or mild cramping, but it should not be painful. In some cases, regional or general anesthesia might be used, especially if other procedures are being performed simultaneously or if the patient prefers it.
Like any medical procedure, hysteroscopy carries some risks, although they are generally low. Potential complications include:
Your doctor will discuss these risks with you and take precautions to minimize them.
It is crucial to consult a doctor if you experience any symptoms suggestive of uterine cancer, especially:
Early detection is key to successful treatment and improved outcomes for uterine cancer. Do not ignore persistent or unusual symptoms. Discussing your concerns with a healthcare provider is the first and most important step towards diagnosis and appropriate management.
Disclaimer: This blog post is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026